Cymbalta

This page contains recent news articles, when available, and an overview of Cymbalta but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Cymbalta
(when available)

Pharmacology and use:
Duloxetine is in a class of medications called selective serotonin and norepinephrine reuptake inhibitors (SSNRIs) and primarily targets major depressive disorders (MDD) and stress urinary incontinence (SUI). Duloxetine is also used to treat pain and tingling caused by diabetic neuropathy (damage to nerves that can develop in people who have diabetes). Known also as LY248686, it is a potent dual inhibitor of serotonin (5-hydroxytryptamine, 5-HT) and norepinephrine (NE) reuptake, possessing comparable affinities in binding to NE and 5-HT transport sites. Interestingly, its behavior contrasts to most other dual-reuptake inhibitors. Furthermore, duloxentine lacks affinity for monoamine receptors within the central nervous system. For the treatment of major depressive disorder (MDD).

Mechanism Of Action:
Duloxetine is a potent inhibitor of neuronal serotonin and norepinephrine reuptake and a less potent inhibitor of dopamine reuptake. Duloxetine has no significant affinity for dopaminergic, adrenergic, cholinergic, histaminergic, opioid, glutamate, and GABA receptors. The antidepressant and pain inhibitory actions of duloxetine are believed to be related to its potentiation of serotonergic and noradrenergic activity in the CNS.

News Articles on Duloxetine

Depression and The Recession: Cymbalta Sales Are on the Rise  -  30 Aug 2009
Last month, Eli Lilly reported that second-quarter sales for Cymbalta -- which is on the verge of surpassing Effexor as the nation's best-selling Washington Post

Cymbalta is able to treat depression  -  ‎Aug 28, 2009‎
The best thing that is able to improve your mood and return your life is Cymbalta. It also can manage with diabetic nerve pain (DNP). MichiganPR.net (press release)

Lilly moves on from Prozac to Cymbalta  -  ‎Aug 23, 2009‎
The company laid off employees but went on to introduce replacements, notably Cymbalta. But Lilly and other pharmaceutical giants face a market in which United Press International

UnitedHealth: Stick to Your Meds, Get $20 Off Next Prescription  -  ‎Aug 28, 2009‎
Drugs that will be eligible for the discount include antidepressants such as Eli Lilly's Cymbalta and Wyeth's Effexor XR, and asthma drugs such as Wall Street Journal Blogs

Q&A: Antidepressants  -  ‎Aug 28, 2009‎
A newer class of antidepressants called "SNRIs," or sometimes "SSNRIs," which includes the drugs Effexor and Cymbalta, affects serotonin as well as another Sampan

Drugmakers willing to pay to get doctor's approval  -  ‎Aug 28, 2009‎
For the first time, Floridians can see if their doctors juggled patient appointments with speaking gigs for the maker of popular drugs like Cymbalta, Tampabay.com

TALK ABOUT PULLING THE PLUG ON GRANDMA  -  ‎Aug 25, 2009‎
Eli Lilly's second best-selling drug is an antidepressant called Cymbalta, one of the new-fangled anti-depressants that carry serious risks, which you could NewsWithViews.com

The challenge of happy pills  -  ‎Aug 25, 2009‎
That's good news for Eli Lilly and Co., which gave the world Prozac and Cymbalta, right? Lilly has gotten a lot of mileage from its branded antidepressants Indianapolis Star

Drugs suspected in crash  -  ‎Aug 11, 2009‎
Cymbalta can cause nausea and dizziness. Trooper Jared Reilly interviewed Hubbs after the crash. “He had a sleepy appearance,� Reilly wrote in an affidavit. Jackson Hole Daily

Lilly makes buyout offer to 4000 sales reps  -  ‎Aug 4, 2009‎
The company's best-selling drugs include Zyprexa for schizophrenia and bipolar disorder, Cymbalta for depression, Byetta for type 2 diabetes, and Evista for The Associated Press

Research and Markets: Forecast Insight: Fibromyalgia - Regulatory ...  -  ‎Aug 29, 2009‎
Since 2008, the EMEA has declined marketing applications for both Cymbalta (duloxetine, Eli Lilly/Boehringer Ingelheim) and Lyrica (pregabalin, Pfizer). Earthtimes (press release)

Police Blotter  -  ‎Aug 5, 2009‎
A Lily Drug company bag containing 15 boxes of Cymbalta 30 mg and Cymbalta 60 mg were stolen from inside black Chevy Malibu in the 200 block of Alhambra Palm Beach Post

Suicide Risks From Antidepressants Vary With Age, FDA Says  -  ‎Aug 12, 2009‎
Antidepressants like Prozac, Paxil, Zoloft, Lexapro, and Cymbalta are taken by millions of Americans, but they have been associated with increased risks of Attorney at Law

'I'm one of those moms on meds'  -  ‎Aug 28, 2009‎
They compared the benefits and side effects Paxil, Lexapro, Cymbalta, Prozac and others. Some made you gain weight, some made you lose. Tampabay.com

Drug Company Discloses How Much It Paid Doctors  -  ‎Aug 5, 2009‎
They manufacture mediciations like depression drugs Prozac and Cymbalta, as well as Cialis for sexual enhancement. They also pay 3400 physicians for KGTV, 10News.com

Free or Low-Cost Drugs for Fibromyalgia & Chronic Fatigue Syndrome  -  ‎Aug 12, 2009‎
Newer medications like Lyrica, Cymbalta and Savella are expensive, and a lot of insurance companies won't foot the bill. I've been there, paying about $300 About - News & Issues

Duloxetine linked to serotonin syndrome  -  ‎Aug 5, 2009‎
The serotonin and noradrenaline reuptake inhibitor duloxetine (Cymbalta) could be associated with serotonin syndrome, the latest ADRAC bulletin reports. Psychiatry Update

What Is Postherpetic Neuralgia? What Causes Postherpetic Neuralgia?  -  ‎Aug 10, 2009‎
...desipramine (Norpramin), nortriptyline (Pamelor) and duloxetine (Cymbalta). They will not get rid of the pain, but are said to make it more bearable. Medical News Today

Stonefly Communications Group Announces New Appointments  -  ‎Aug 27, 2009‎
Weatherby has worked on healthcare brands such as Cymbalta, Alimta, Vidaza, Topamax and Razadyne. "We are thrilled that Stonefly has attracted such a PharmaLive.com (press release)

Eli Lilly shares on Goldman analyst downgrades  -  ‎Aug 10, 2009‎
...$10 billion in sales between 2010 and 2015 as patents expire on the anti-psychotic Zyprexa, antidepressant Cymbalta, the insulin Humalog, and others. The Associated Press

Health Advice: Will Neurontin Work as Well as Lyrica for Fibromyalgia?  -  ‎Aug 19, 2009‎
Cymbalta (duloxetine) and the just-released drug Savella (milnacipran) block the reuptake of the neurotransmitters norepinephrine and serotonin and hence U.S. News & World Report

SNRIs Effective for Depression  -  ‎Aug 26, 2009‎
Currently, two of the drugs have been approved as antidepressants in Germany: venlafaxine (Effexor) and duloxetine (Cymbalta). According to the report, PsychCentral.com

'Detrusor Overactivity' Affects Many Women  -  ‎Aug 19, 2009‎
There is also some preliminary evidence that the antidepressant Cymbalta® may have an effect on the urethra. Unfortunately, these medications only help the Space Coast Medicine and Healthy Living

Nycomed Deal Gets Forest New Shot at COPD Market  -  ‎Aug 10, 2009‎
...s Cymbalta (duloxetine). Other potential near-term products include ceftaroline, an antibiotic that has met endpoints in late-stage trials in BioWorld Online

Patent Protection of Key Blockbuster Agents for Major Depression ...  -  ‎Aug 17, 2009‎
...these countries and the patent protection of key agents that include Lundbeck/Forest's Lexapro and Eli Lilly/Boehringer Ingelheim's Cymbalta/Xeristar. PR Newswire (press release)

Sharon Miller's Words for Women: Fibromyalgia: There is hope  -  ‎Aug 11, 2009‎
Among drugs approved by the US Food and Drug Administration to treat FM are Lyrica (pregabalin), Cymbalta (duloxetine HCl) and Savella (milnacipran HCl). Baxter Bulletin

Suicide Prevention Drug Pushing Racket - Part I  -  ‎Aug 6, 2009‎
According to his online CV, Robert Valuck has been a consultant to Eli Lilly, maker of the antidepressants, Prozac, Cymbalta, and Sybyax, since 2005, Natural News.com

20/20 Tackles Taboo Health Issue Affecting Millions of Women  -  ‎Aug 10, 2009‎
...including nerve blocks, topical creams and oral "pain-blocking" medications such as antidepressants (Cymbalta) or anticonvulsants (Lyrica). PR Newswire (press release)

All Doped Up  -  ‎Aug 5, 2009‎
Sales topped $11 billion in 2008. Two drugs, Effexor and Cymbalta, captured half the market share, $6.63 billion. It's a fast way to make a buck. The New American

Area doctors paid by Eli Lilly: Several Roanoke health care ...  -  ‎Aug 13, 2009‎
Lilly's second best-selling drug is Cymbalta, which is used for treating depression and anxiety. Revenues for Cymbalta totaled $744.4 million for the three Trading Markets (press release)

Los pasos de los pesos(César Castruita | )  -  ‎Aug 28, 2009‎
...los laboratorios Eli Lilly, de Carlos Baños; y Boehringer Ingelheim, de Thorsten Pohl, creadores del medicamento Cymbalta (duloxetina), se dio a conocer La Crónica de Hoy

La crisis ayuda a la venta de Prozac  -  ‎Aug 20, 2009‎
Detalló que en el mercado de antidepresivos Eli Lilly participa con dos de los medicamentos más comercializados, Prozac y Cymbalta. Excélsior

"VI BEHANDLADE BARA SYMTOM - VI BOTADE INTE." FD ANSTÄLLD INOM ...  -  ‎Aug 17, 2009‎
Hypnotisera dem och droga ner dem och forsla dem till en psykiatriker så att de kan svälja sin nästa Cymbalta eller Prozac eller vad de nu kommer att kalla Newsdesk (pressmeddelande)

Apotheker klagen über Liefernotstand  -  ‎Aug 27, 2009‎
Cipralex (Lundbeck), Persantin (Boehringer), Keppra (UCB), Cellcept (Roche), Aprovel/CoAprovel (Sanofi), Femara (Novartis) und Cymbalta (Lilly). apotheke-adhoc

SNRI nützen bei Depressionen  -  ‎Aug 18, 2009‎
Berlin - Die beiden selektiven Serotonin- und Noradrenalin-Wiederaufnahmehemmer (SNRI) Venlafaxin (Trevilor, Wyeth) und Duloxetin (Cymbalta/Yentreve, apotheke-adhoc

Brand Names/Synonyms:
Cymbalta is also known by the following brand names and/or synonymsCymbalta; Domperidone; Duloxetine; Duloxetine Hcl; Duloxetine Hydrochloride; Yentreve

Drug Category:
Cymbalta is categorized under the following by the FDA: Antidepressants; ATC:N06AB

Dosage Forms:
CAPSULE

Absorption:
Orally administered duloxetine hydrochloride is well absorbed.

Interactions:
Interactions for Duloxetine: Potential for Other Drugs to Affect Duloxetine: Both CYP1A2 and CYP2D6 are responsible for duloxetine metabolism. Inhibitors of CYP1A2: Concomitant use of duloxetine with fluvoxamine, an inhibitor of CYP1A2, results in approximately a 6-fold increase in AUC and about a 2.5-fold increase in Cmax of duloxetine. Some quinolone antibiotics would be expected to have similar effects and these combinations should be avoided. Inhibitors of CYP2D6: Because CYP2D6 is involved in duloxetine metabolism, concomitant use of duloxetine with potent inhibitors of CYP2D6 may result in higher concentrations of duloxetine. Paroxetine (20 mg QD) increased the concentration of duloxetine (40 mg QD) by about 60%, and greater degrees of inhibition are expected with higher doses of paroxetine. Similar effects would be expected with other potent CYP2D6 inhibitors (e.g., fluoxetine, quinidine). Potential for Duloxetine to Affect Other Drugs: Drugs Metabolized by CYP1A2: In vitro drug interaction studies demonstrate that duloxetine does not induce CYP1A2 activity, and it is unlikely to have a clinically significant effect on the metabolism of CYP1A2 substrates. Drugs Metabolized by CYP2D6: Duloxetine is a moderate inhibitor of CYP2D6. When duloxetine was administered (at a dose of 60 mg BID) in conjunction with a single 50-mg dose of desipramine, a CYP2D6 substrate, the AUC of desipramine increased 3-fold. Therefore, co-administration of Duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index, including certain antidepressants (tricyclic antidepressants [TCAs], such as nortriptyline, amitriptyline, and imipramine), phenothiazines and Type 1C antiarrhythmics (e.g., propafenone, flecainide), should be approached with caution. Plasma TCA concentrations may need to be monitored and the dose of the TCA may need to be reduced if a TCA is co-administered with Duloxetine. Because of the risk of serious ventricular arrhythmias and sudden death potentially associated with elevated plasma levels of thioridazine, Duloxetine and thioridazine should not be co-administered. Drugs Metabolized by CYP3A: Results of in vitro studies demonstrate that duloxetine does not inhibit or induce CYP3A activity. Duloxetine May Have a Clinically Important Interaction with the Following Other Drugs: Alcohol: When Duloxetine and ethanol were administered several hours apart so that peak concentrations of each would coincide, Duloxetine did not increase the impairment of mental and motor skills caused by alcohol. In the Duloxetine clinical trials database, three Duloxetine-treated patients had liver injury as manifested by ALT and total bilirubin elevations, with evidence of obstruction. Substantial intercurrent ethanol use was present in each of these cases, and this may have contributed to the abnormalities seen. CNS Acting Drugs: Given the primary CNS effects of Duloxetine, it should be used with caution when it is taken in combination with or substituted for other centrally acting drugs, including those with a similar mechanism of action. Potential for Interaction with Drugs that Affect Gastric Acidity: Duloxetine has an enteric coating that resists dissolution until reaching a segment of the gastrointestinal tract where the pH exceeds 5.5. In extremely acidic conditions, Duloxetine, unprotected by the enteric coating, may undergo hydrolysis to form naphthol. Caution is advised in using Duloxetine in patients with conditions that may slow gastric emptying (e.g., some diabetics). Drugs that raise the gastrointestinal pH may lead to an earlier release of duloxetine. However, co-administration of Duloxetine with aluminum- and magnesium-containing antacids (51 mEq) or Duloxetine with famotidine, had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose. It is unknown whether the concomitant administration of proton pump inhibitors affects duloxetine absorption.



Chemical IUPAC Name:
N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-yl-propan-1-amine

:
 
Web health.mongabay.com/health


Health Home | Conditions | Cancer | Medications | Surgery | Vaccines

mongabay.com


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com/health lead to other sites. health.mongabay.com/health does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com/health responsible for dead or misdirected links.

IF YOU NEED A LINK/TEXT REMOVED FROM THIS PAGE, PLEASE CONTACT: mongabay (at) gmail.com


COPYRIGHT 2007 MONGABAY.COM